{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:23:23Z","timestamp":1791318203484,"version":"4.3.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T00:00:00Z","timestamp":1726531200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Formosan Medical Association"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.jfma.2024.09.018","type":"journal-article","created":{"date-parts":[[2024,10,5]],"date-time":"2024-10-05T07:51:24Z","timestamp":1728114684000},"page":"931-937","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Ranolazine effects on exercise tolerance and angina frequency in Taiwanese stable angina: A bridging study of the CARISA randomized trial"],"prefix":"10.1016","volume":"124","author":[{"given":"Jen-Kuang","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I-Chang","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Hsun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1520-1166","authenticated-orcid":false,"given":"Yen-Wen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Chung","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7082-932X","authenticated-orcid":false,"given":"Jen-Yuan","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Yuan","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Hsueh","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6437-0455","authenticated-orcid":false,"given":"Juey-Jen","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfma.2024.09.018_bib1","unstructured":"https:\/\/www.who.int\/data\/gho\/data\/themes\/mortality-and-global-health-estimates."},{"key":"10.1016\/j.jfma.2024.09.018_bib2","series-title":"Coronary heart disease syndromes: pathophysiology and clinical recognition, Coronary Artery Disease","first-page":"365","author":"Willerson","year":"2015"},{"key":"10.1016\/j.jfma.2024.09.018_bib3","doi-asserted-by":"crossref","unstructured":"PH Joshi, JA De Lemos, Diagnosis and management of stable angina: a review, J Am Med Assoc 325 (17), 1765\u20131778..","DOI":"10.1001\/jama.2021.1527"},{"issue":"38","key":"10.1016\/j.jfma.2024.09.018_bib4","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1093\/eurheartj\/eht296","article-title":"ESC guidelines on the management of stable coronary artery disease: the task force on the management of stable coronary artery disease of the European society of cardiology","volume":"34","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jfma.2024.09.018_bib5","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1161\/CIRCULATIONAHA.107.720953","article-title":"Prevalence of angina in women versus men: a systematic review and metaanalysis of international variations across 31 countries","volume":"117","author":"Hemingway","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jfma.2024.09.018_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijcard.2019.01.061","article-title":"A decline in the prevalence of angina pectoris: data from the nutrition and Health survey in taiwan","volume":"280","author":"Tsai","year":"2019","journal-title":"Int J Cardiol"},{"issue":"10","key":"10.1016\/j.jfma.2024.09.018_bib7","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.acvd.2011.08.001","article-title":"Update on the medical treatment of stable angina","volume":"104","author":"Gayet","year":"2011","journal-title":"Arch Cardiovasc Dis"},{"issue":"2","key":"10.1016\/j.jfma.2024.09.018_bib8","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1161\/01.CIR.90.2.762","article-title":"Affiliations Effects of treatment on outcome in mildly symptomatic patients with ischemia during daily life. The Atenolol Silent Ischemia","volume":"90","author":"Pepine","year":"1994","journal-title":"Study (ASIST), Circulation."},{"issue":"1","key":"10.1016\/j.jfma.2024.09.018_bib9","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/oxfordjournals.eurheartj.a014699","article-title":"The Total Ischaemic Burden European Trial (TIBET). Effects of atenolol, nifedipine SR and their combination on the exercise test and the total ischaemic burden in 608 patients with stable angina. The TIBET Study Group","volume":"17","author":"Fox","year":"1996","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.jfma.2024.09.018_bib10","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/oxfordjournals.eurheartj.a014695","article-title":"Effects of metoprolol vs verapamil in patients with stable angina pectoris. The Angina Prognosis Study in Stockholm (APSIS)","volume":"17","author":"Rehnqvist","year":"1996","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.jfma.2024.09.018_bib11","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1177\/1741826711409325","article-title":"Long-term beta blockers for stable angina: systematic review and meta-analysis","volume":"19","author":"Shu","year":"2012","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.jfma.2024.09.018_bib12","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1001\/jama.2012.12559","article-title":"REACH Registry Investigators. \u03b2-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease","volume":"308","author":"Bangalore","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.jfma.2024.09.018_bib13","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1161\/CIRCOUTCOMES.114.001073","article-title":"\u03b2-blockers and cardiovascular events in patients with and without myocardial infarction: post hoc analysis from the CHARISMA trial","volume":"7","author":"Bangalore","year":"2014","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jfma.2024.09.018_bib14","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/CRD.0b013e3181c8e14a","article-title":"Nitrates and nitrites in the treatment of ischemic cardiac disease","volume":"18","author":"Nossaman","year":"2010","journal-title":"Cardiol Rev"},{"key":"10.1016\/j.jfma.2024.09.018_bib15","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1517\/14740338.5.5.667","article-title":"Side effects of using nitrates to treat angina","volume":"5","author":"Thadani","year":"2006","journal-title":"Expet Opin Drug Saf"},{"issue":"25","key":"10.1016\/j.jfma.2024.09.018_bib16","first-page":"e354","volume":"126","author":"Fihn","year":"2012","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.jfma.2024.09.018_bib17","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1177\/1074248417698224","article-title":"Antianginal therapy for stable ischemic heart disease: a contemporary review","volume":"22","author":"Padala","year":"2017","journal-title":"J Cardiovasc Pharmacol Therapeut"},{"key":"10.1016\/j.jfma.2024.09.018_bib18","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ijcard.2018.12.008","article-title":"Anti-anginal drugs: systematic review and clinical implications","volume":"283","author":"Pavasini","year":"2019","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jfma.2024.09.018_bib19","series-title":"Ranolazine","author":"Reed","year":"2022"},{"issue":"8","key":"10.1016\/j.jfma.2024.09.018_bib20","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.jacc.2003.11.045","article-title":"Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina","volume":"43","author":"Chaitman","year":"2004","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.jfma.2024.09.018_bib21","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1001\/jama.291.3.309","article-title":"Combination Assessment of Ranolazine in Stable Angina (CARISA) Investigators, Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial","volume":"291","author":"Chaitman","year":"2004","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.jfma.2024.09.018_bib22","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1093\/eurheartj\/ehi495","article-title":"Effects of ranolazine on exercise tolerance and HbA1c in patients with chronic angina and diabetes","volume":"27","author":"Timmis","year":"2006","journal-title":"Eur Heart J"},{"issue":"8","key":"10.1016\/j.jfma.2024.09.018_bib23","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1093\/ptj\/80.8.782","article-title":"Submaximal exercise testing: clinical application and interpretation","volume":"80","author":"Noonan","year":"2000","journal-title":"Phys Ther"},{"issue":"3","key":"10.1016\/j.jfma.2024.09.018_bib24","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.jacc.2006.05.044","article-title":"Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA (Efficacy of Ranolazine in Chronic Angina) trial","volume":"48","author":"Stone","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"20","key":"10.1016\/j.jfma.2024.09.018_bib25","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1016\/j.jacc.2013.02.011","article-title":"Evaluation of ranolazine in patients with type 2 diabetes mellitus and chronic stable angina: results from the TERISA randomized clinical trial (Type 2 Diabetes Evaluation of Ranolazine in Subjects with Chronic Stable Angina)","volume":"61","author":"Kosiborod","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jfma.2024.09.018_bib26","article-title":"Effects of Ranolazine on various outcomes in patients with stable angina: an updated meta-analysis","author":"Manolis","year":"2022","journal-title":"Hellenic J Cardiol"},{"issue":"1","key":"10.1016\/j.jfma.2024.09.018_bib27","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3390\/ph15010031","article-title":"Ranolazine: an old drug with emerging potential; lessons from pre-clinical and clinical investigations for possible repositioning","volume":"15","author":"Rouhana","year":"2021","journal-title":"Pharmaceuticals"},{"issue":"5","key":"10.1016\/j.jfma.2024.09.018_bib28","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1177\/1060028016631757","article-title":"Ranolazine and its effects on hemoglobin A1C","volume":"50","author":"Greiner","year":"2016","journal-title":"Ann Pharmacother"},{"issue":"5","key":"10.1016\/j.jfma.2024.09.018_bib29","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.hrthm.2015.01.021","article-title":"RAFFAELLO investigators, ranolazine in the treatment of atrial fibrillation: results of the dose-ranging RAFFAELLO (ranolazine in atrial fibrillation following an ELectricaL CardiOversion) study","volume":"12","author":"Ferrari","year":"2015","journal-title":"Heart Rhythm"},{"issue":"5","key":"10.1016\/j.jfma.2024.09.018_bib30","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1161\/CIRCEP.115.002856","article-title":"The HARMONY trial: combined ranolazine and dronedarone in the management of paroxysmal atrial fibrillation: mechanistic and therapeutic synergism","volume":"8","author":"Reiffel","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"3","key":"10.1016\/j.jfma.2024.09.018_bib31","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1177\/1060028016673073","article-title":"Novel use of ranolazine as an antiarrhythmic agent in atrial fibrillation","volume":"51","author":"White","year":"2017","journal-title":"Ann Pharmacother"},{"issue":"5","key":"10.1016\/j.jfma.2024.09.018_bib32","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1177\/1060028016631757","article-title":"Ranolazine and its effects on hemoglobin A1C","volume":"50","author":"Greiner","year":"2016","journal-title":"Ann Pharmacother"}],"container-title":["Journal of the Formosan Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664624004388?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664624004388?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T04:33:01Z","timestamp":1758947581000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929664624004388"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":32,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S0929664624004388"],"URL":"https:\/\/doi.org\/10.1016\/j.jfma.2024.09.018","relation":{},"ISSN":["0929-6646"],"issn-type":[{"value":"0929-6646","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ranolazine effects on exercise tolerance and angina frequency in Taiwanese stable angina: A bridging study of the CARISA randomized trial","name":"articletitle","label":"Article Title"},{"value":"Journal of the Formosan Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfma.2024.09.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2025, Formosan Medical Association. Published by Elsevier Taiwan LLC. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}